Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 1,579.35 | 74.70 | 3.00 | 9.54 |
Short Term Investments | 3,079.19 | 869.36 | 1,080.85 | 1,579.48 |
Cashand Short Term Investments | 4,658.54 | 1,143.65 | 1,313.03 | 1,753.70 |
Accounts Receivable- Trade Net | 2,252.81 | 2,234.49 | 1,944.59 | 1,646.97 |
Total Receivables Net | 2,261.88 | 2,865.32 | 2,561.23 | 2,363.03 |
Total Inventory | 2,661.18 | 2,728.93 | 3,063.01 | 2,331.73 |
Other Current Assets Total | 829.98 | 1,947.39 | 1,441.72 | 450.00 |
Total Current Assets | 10,411.58 | 8,729.68 | 8,435.43 | 6,928.82 |
Property/ Plant/ Equipment Total- Net | 2,557.03 | 2,513.52 | 2,765.93 | 2,706.43 |
Goodwill Net | 416.74 | 413.17 | 403.09 | 395.39 |
Intangibles Net | 57.58 | 79.38 | 72.19 | 84.44 |
Long Term Investments | 455.02 | 524.87 | 880.26 | 158.58 |
Note Receivable- Long Term | 78.17 | 149.78 | 168.56 | 99.30 |
Other Long Term Assets Total | 1,598.78 | 1,346.23 | 1,343.73 | 1,146.30 |
Total Assets | 15,574.90 | 13,756.63 | 14,069.19 | 11,519.26 |
Accounts Payable | 1,748.12 | 1,165.03 | 1,173.38 | 1,069.41 |
Current Portof LT Debt/ Capital Leases | 1,189.15 | 19.20 | 21.60 | 58.38 |
Other Currentliabilities Total | 1,057.28 | 615.39 | 463.27 | 396.84 |
Total Current Liabilities | 3,994.55 | 3,707.15 | 4,805.34 | 3,604.05 |
Long Term Debt | 40.00 | 0.00 | 9.38 | 27.93 |
Capital Lease Obligations | 189.26 | 70.33 | 66.47 | 69.71 |
Total Long Term Debt | 229.26 | 70.33 | 75.85 | 97.64 |
Total Debt | 1,418.41 | 1,396.68 | 2,668.19 | 1,791.98 |
Minority Interest | 402.34 | 389.71 | 209.43 | 181.28 |
Other Liabilities Total | 636.69 | 544.15 | 340.67 | 259.56 |
Total Liabilities | 5,262.84 | 4,711.34 | 5,431.29 | 4,142.53 |
Common Stock Total | 23.91 | 23.91 | 23.91 | 23.91 |
Retained Earnings( Accumulated Deficit) | 10,288.15 | 8,873.73 | 8,581.66 | 7,354.52 |
Total Equity | 10,312.06 | 9,045.29 | 8,637.90 | 7,376.73 |
Total Liabilities Shareholders' Equity | 15,574.90 | 13,756.63 | 14,069.19 | 11,519.26 |
Total Common Shares Outstanding | 11.96 | 11.96 | 11.96 | 11.96 |
Tangible Book Valueper Share Common Eq | 822.90 | 715.32 | 682.69 | 576.83 |
Cash | - | 199.59 | 229.18 | 164.68 |
Prepaid Expenses | - | 44.39 | 56.44 | 30.36 |
Property/ Plant/ Equipment Total- Gross | - | 3,735.27 | 3,913.16 | 3,573.57 |
Accumulated Depreciation Total | - | -1,221.75 | -1,147.28 | -867.18 |
Accrued Expenses | - | 600.38 | 576.35 | 443.46 |
Notes Payable/ Short Term Debt | - | 1,307.15 | 2,570.74 | 1,635.96 |
ESOP Debt Guarantee | - | 0.60 | 0.60 | 1.12 |
Other Equity Total | - | 147.05 | 31.73 | -2.82 |
Alkem Laboratories Dividend Alkem Laboratories Bonus Alkem Laboratories News Alkem Laboratories AGM Alkem Laboratories Rights Alkem Laboratories Splits Alkem Laboratories Board Meetings Alkem Laboratories Key Metrics Alkem Laboratories Shareholdings Alkem Laboratories Profit Loss Alkem Laboratories Cashflow Alkem Laboratories Q1 Results Alkem Laboratories Q2 Results Alkem Laboratories Q3 Results Alkem Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks